# Hugo A. Katus

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hugo-a-katus/

## Facts

| Field | Value |
| --- | --- |
| Citations | 174,893 |
| Field | Cardiac Imaging and Diagnostics |
| h-index | 146 |
| i10-index | 1,162 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5049262839 |
| ORCID iD | https://orcid.org/0000-0002-2293-2314 |
| Works | 2,126 |

## Researcher papers

Showing 12 of 35.

- [2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-i-lipid/)
- [2018 ESC/EACTS Guidelines on myocardial revascularization](https://scholariq.org/papers/2018-esc-eacts-guidelines-on-myocardial-revascularization/)
- [Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes](https://scholariq.org/papers/ticagrelor-versus-clopidogrel-in-patients-with-acute-coronary-syndromes/)
- [2017 ESC/EACTS Guidelines for the management of valvular heart disease](https://scholariq.org/papers/2017-esc-eacts-guidelines-for-the-management-of-valvular-heart-disease/)
- [2021 ESC/EACTS Guidelines for the management of valvular heart disease](https://scholariq.org/papers/2021-esc-eacts-guidelines-for-the-management-of-valvular-heart-disease-2/)
- [2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk](https://scholariq.org/papers/2019-esc-eas-guidelines-for-the-management-of-dyslipidaemias-lipid-modification/)
- [Effect of Carvedilol on Survival in Severe Chronic Heart Failure](https://scholariq.org/papers/effect-of-carvedilol-on-survival-in-severe-chronic-heart-failure-2/)
- [Third universal definition of myocardial infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction-3/)
- [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS](https://scholariq.org/papers/2017-esc-focused-update-on-dual-antiplatelet-therapy-in-coronary-artery-disease/)
- [Third Universal Definition of Myocardial Infarction](https://scholariq.org/papers/third-universal-definition-of-myocardial-infarction/)
- [Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy](https://scholariq.org/papers/clinical-features-and-outcomes-of-takotsubo-stress-cardiomyopathy/)
- [Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction](https://scholariq.org/papers/universal-definition-of-myocardial-infarction-kristian-thygesen-joseph-s-alpert/)

## Researcher topics

- [Cardiac Imaging and Diagnostics](https://scholariq.org/topics/cardiac-imaging-and-diagnostics/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)
- [Cardiac electrophysiology and arrhythmias](https://scholariq.org/topics/cardiac-electrophysiology-and-arrhythmias/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiomyopathy and Myosin Studies](https://scholariq.org/topics/cardiomyopathy-and-myosin-studies/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.